share_log

8-K: Poll Results of 2024 Annual Meeting of Shareholders

8-K: Poll Results of 2024 Annual Meeting of Shareholders

8-K:2024年股東大會投票結果
美股sec公告 ·  05/10 04:59
牛牛AI助理已提取核心訊息
Bristol-Myers Squibb Company held its Annual Meeting on May 7, 2024, where several key decisions were made by its shareholders. The election of the company's 10 nominees to the Board of Directors was confirmed, with each director receiving a significant majority of votes for their appointment until the 2025 Annual Meeting. Additionally, the advisory vote to approve the compensation of the company's named executive officers was passed. Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2024. A management proposal to amend the company's Amended and Restated Certificate of Incorporation for limiting executive officers' monetary liability for breach of duty of care was approved. However, two shareholder proposals, one for adopting a policy that the Chairperson of the Board be an independent director, and another concerning Executive Retention of Significant Stock, were not approved. The meeting concluded with the inclusion of a Certificate of Amendment effective as of May 7, 2024, as part of the Current Report on Form 8-K.
Bristol-Myers Squibb Company held its Annual Meeting on May 7, 2024, where several key decisions were made by its shareholders. The election of the company's 10 nominees to the Board of Directors was confirmed, with each director receiving a significant majority of votes for their appointment until the 2025 Annual Meeting. Additionally, the advisory vote to approve the compensation of the company's named executive officers was passed. Shareholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2024. A management proposal to amend the company's Amended and Restated Certificate of Incorporation for limiting executive officers' monetary liability for breach of duty of care was approved. However, two shareholder proposals, one for adopting a policy that the Chairperson of the Board be an independent director, and another concerning Executive Retention of Significant Stock, were not approved. The meeting concluded with the inclusion of a Certificate of Amendment effective as of May 7, 2024, as part of the Current Report on Form 8-K.
百時美施貴寶公司於2024年5月7日舉行了年會,其股東在會上做出了幾項關鍵決定。公司的10名董事會候選人的選舉得到確認,在2025年年會之前,每位董事的任命都獲得了絕大多數選票。此外,批准公司指定執行官薪酬的諮詢投票獲得通過。股東批准任命德勤會計師事務所爲2024年的獨立註冊會計師事務所。管理層關於修改公司經修訂和重述的公司註冊證書以限制執行官因違反謹慎義務而承擔的金錢責任的提案獲得批准。但是,兩項股東提案未獲批准,一項是通過董事會主席爲獨立董事的政策,另一項是關於高管保留重要股票的提案。會議結束時納入了自2024年5月7日起生效的修正證書,作爲8-K表最新報告的一部分。
百時美施貴寶公司於2024年5月7日舉行了年會,其股東在會上做出了幾項關鍵決定。公司的10名董事會候選人的選舉得到確認,在2025年年會之前,每位董事的任命都獲得了絕大多數選票。此外,批准公司指定執行官薪酬的諮詢投票獲得通過。股東批准任命德勤會計師事務所爲2024年的獨立註冊會計師事務所。管理層關於修改公司經修訂和重述的公司註冊證書以限制執行官因違反謹慎義務而承擔的金錢責任的提案獲得批准。但是,兩項股東提案未獲批准,一項是通過董事會主席爲獨立董事的政策,另一項是關於高管保留重要股票的提案。會議結束時納入了自2024年5月7日起生效的修正證書,作爲8-K表最新報告的一部分。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。